Announced Wed, 19 Aug, 2026 · 16:34 IST
Krsnaa Diagnostics Q1 FY27 earnings call transcript; revenue up 22%, EBITDA margin 25%
Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansOrder Pipeline DisclosedMgmt Evaded Key QuestionInvestor Communications View source PDFExplain this filing
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.8%1-day move
₹534.60
prior close
₹535.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.4+0.4+1.0+4.8+6.1+4.9+4.9+4.4+4.0+5.4+3.3——
Up moveDown movePending
AI summary
Krsnaa Diagnostics posted Q1 FY27 revenue of INR 2,355 million, up 22% year-on-year. EBITDA margin of 25% versus 27% a year ago was hit by upfront staffing costs for the Rajasthan project. PAT was INR 166 million (7% margin). Retail revenue grew 64% year-on-year to INR 193 million. The company won a 34-center CT project in Himachal Pradesh and targets retail EBITDA-positive by Q2. Margins are expected to recover to double digits by year-end.
Likely market impact
Reaffirms a strong growth runway from Rajasthan ramp-up, retail scale-up, and new project wins, with margins set to recover as upfront costs normalize.